Tech Company Financing Transactions

AveXis Funding Round

T. Rowe Price, Adage Capital Management and Deerfield Capital participated in a $65 million Series D funding round for AveXis. The financing round was announced on 9/9/2015.

Transaction Overview

Company Name
AveXis
Announced On
9/9/2015
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series D
Investors

T. Rowe Price (Lead Investor) (Taymour Tamaddon)

Adage Capital Management

Deerfield Capital (Jonathan Leff)

Foresite Capital

Janus Capital

QVT Fund

RA Capital

Roche Venture Fund (Carole Nuechterlein)

Rock Springs Capital

Tavistock Life Sciences

Venrock (Bong Koh)

Proceeds Purpose
The proceeds will be used to advance the company's ongoing spinal muscular atrophy (SMA) clinical program and expand key operational capabilities.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2275 Half Day Rd. 200
Bannockburn, IL 60015
USA
Phone
(847) 572-8280
Website
www.avexis.com
Email Address
[email protected]
Overview
AveXis is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases, like spinal muscular atrophy (SMA).
Profile
AveXis LinkedIn Company Profile
Social Media
AveXis Company Twitter Account
Company News
AveXis News
Facebook
AveXis on Facebook
YouTube
AveXis on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sean Nolan
  Sean Nolan LinkedIn Profile  Sean Nolan Twitter Account  Sean Nolan News  Sean Nolan on Facebook
Chief Financial Officer
Phillip Donenberg
  Phillip Donenberg LinkedIn Profile  Phillip Donenberg Twitter Account  Phillip Donenberg News  Phillip Donenberg on Facebook
Chief Medical Officer
Sukumar Nagendran
  Sukumar Nagendran LinkedIn Profile  Sukumar Nagendran Twitter Account  Sukumar Nagendran News  Sukumar Nagendran on Facebook
Chief Scientific Officer
Allan Kaspar
  Allan Kaspar LinkedIn Profile  Allan Kaspar Twitter Account  Allan Kaspar News  Allan Kaspar on Facebook
VP - Bus. Development
Rick Modi
  Rick Modi LinkedIn Profile  Rick Modi Twitter Account  Rick Modi News  Rick Modi on Facebook
VP - Bus. Development
RA Session
  RA Session LinkedIn Profile  RA Session Twitter Account  RA Session News  RA Session on Facebook
VP - General Counsel
Michael Johannesen
  Michael Johannesen LinkedIn Profile  Michael Johannesen Twitter Account  Michael Johannesen News  Michael Johannesen on Facebook
VP - Human Resources
Lori Smith
  Lori Smith LinkedIn Profile  Lori Smith Twitter Account  Lori Smith News  Lori Smith on Facebook
VP - Manufacturing
Andrew Knudten
  Andrew Knudten LinkedIn Profile  Andrew Knudten Twitter Account  Andrew Knudten News  Andrew Knudten on Facebook
VP - Regulatory Affairs
James L'Italien
  James L'Italien LinkedIn Profile  James L'Italien Twitter Account  James L'Italien News  James L'Italien on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/9/2015: Trunomi venture capital transaction
Next: 9/9/2015: Trading Ticket venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.